A Study to Learn More About Copanlisib Treatment Patterns in People With Indolent Non-Hodgkin Lymphoma, a Type of Cancer That Grows and Spread Slowly and Develops in the Lymphatic System (a Part of Immune System) in Taiwan Under Real-word Conditions
Clinical trial NCT05217914 · COMPLETED
Trial details
- NCT number
- NCT05217914
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-01
- Primary completion
- 2024-08-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.